Information technologies for vaccine research

被引:22
作者
Brusic, Vladimir
August, J. Thomas
Petrovsky, Nikolai
机构
[1] Inst Infocomm Res, Singapore 119613, Singapore
[2] Univ Queensland, Sch Land & Food Sci, Brisbane, Qld, Australia
[3] Univ Queensland, Inst Mol Biotechnol, Brisbane, Qld, Australia
[4] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA
[5] Flinders Med Ctr, Dept Endocrinol & Diabet, Bedford Pk, SA 5042, Australia
关键词
computational vaccinology; immunoinformatics; immunomics; immunologic databases; T-cell epitope prediction;
D O I
10.1586/14760584.4.3.407
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vaccinology is a combinatorial science which studies the diversity of pathogens and the human immune system, and formulations that can modulate immune responses and prevent or cure disease. Huge amounts of data are produced by genomics and proteomics projects and large-scale screening of pathogen-host and antigen-host interactions. Current developments in computational vaccinology mainly support the analysis of antigen processing and presentation and the characterization of targets of immune response. Future development will also include systemic models of vaccine responses. Immunomics, the large-scale screening of immune processes which includes powerful immunoinformatic tools, offers great promise for future translation of basic immunology research advances into successful vaccines.
引用
收藏
页码:407 / 417
页数:11
相关论文
共 83 条
[11]  
Brusic V., 1999, ICONIP'99. ANZIIS'99 & ANNES'99 & ACNN'99. 6th International Conference on Neural Information Processing. Proceedings (Cat. No.99EX378), P603, DOI 10.1109/ICONIP.1999.845663
[12]   Efficient discovery of immune response targets by cyclical refinement of QSAR models of peptide binding [J].
Brusic, V ;
Bucci, K ;
Schönbach, C ;
Petrovsky, N ;
Zeleznikow, J ;
Kazura, JW .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2001, 19 (05) :405-+
[13]   Molecular immunology databases and data repositories [J].
Brusic, V ;
Zeleznikow, J ;
Petrovsky, N .
JOURNAL OF IMMUNOLOGICAL METHODS, 2000, 238 (1-2) :17-28
[14]  
Brusic Vladimir, 2003, Novartis Found Symp, V254, P3
[15]  
Brusic Vladimir, 2005, Expert Rev Clin Immunol, V1, P145, DOI 10.1586/1744666X.1.1.145
[16]   Real-time measurement of in vitro peptide binding to soluble HLA-A*0201 by fluorescence polarization [J].
Buchli, R ;
VanGundy, RS ;
Hickman-Miller, HD ;
Giberson, CF ;
Bardet, W ;
Hildebrand, WH .
BIOCHEMISTRY, 2004, 43 (46) :14852-14863
[17]   A stochastic model of cytotoxic T cell responses [J].
Chao, DL ;
Davenport, MP ;
Forrest, S ;
Perelson, AS .
JOURNAL OF THEORETICAL BIOLOGY, 2004, 228 (02) :227-240
[18]  
Chaussabel Damien, 2004, Am J Pharmacogenomics, V4, P383, DOI 10.2165/00129785-200404060-00005
[19]   Identification of immunodominant regions among promiscuous HLA-DR-restricted CD4+ T-cell epitopes on the tumor antigen MAGE-3 [J].
Consogno, G ;
Manici, S ;
Facchinetti, V ;
Bachi, A ;
Hammer, J ;
Conti-Fine, BM ;
Rugarli, C ;
Traversari, C ;
Protti, MP .
BLOOD, 2003, 101 (03) :1038-1044
[20]   Emerging approaches for the therapy of autoimmune and chronic inflammatory disease [J].
Cope, AP ;
Feldmann, M .
CURRENT OPINION IN IMMUNOLOGY, 2004, 16 (06) :780-786